Medpace Holdings, Inc. Revenue, Net (Deprecated 2018-01-31)
Medpace Holdings, Inc. (MEDP) reported Revenue, Net (Deprecated 2018-01-31) of $163.08 million for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-01.
Discontinued › Income Statement › Revenue
us-gaap:SalesRevenueNet · last filed 2018-05-01
- Medpace Holdings, Inc. revenue, net (deprecated 2018-01-31) for the quarter ending 2018-03-31 was $163.08M, a 52.96% increase year-over-year.
- Medpace Holdings, Inc. revenue, net (deprecated 2018-01-31) for the quarter ending 2017-12-31 was $112.68M, a 4.10% increase year-over-year.
- Medpace Holdings, Inc. revenue, net (deprecated 2018-01-31) for the quarter ending 2017-09-30 was $110.64M, a 2.64% increase year-over-year.
- Medpace Holdings, Inc. revenue, net (deprecated 2018-01-31) for the quarter ending 2017-06-30 was $106.22M, a 0.25% increase year-over-year.
- Medpace Holdings, Inc. revenue, net (deprecated 2018-01-31) for fiscal 2017 was $436.15M, a 3.46% increase from fiscal 2016.
- Medpace Holdings, Inc. revenue, net (deprecated 2018-01-31) for fiscal 2016 was $421.58M, a 17.41% increase from fiscal 2015.
- Medpace Holdings, Inc. revenue, net (deprecated 2018-01-31) for fiscal 2015 was $359.06M.
| Period end | Revenue, Net (Deprecated 2018-01-31) 3 month | Revenue, Net (Deprecated 2018-01-31) 6 month | Revenue, Net (Deprecated 2018-01-31) 9 month | Revenue, Net (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|
| 2018-03-31 | $163.08M 10-Q · filed 2018-05-01 | $275.76M derived: sum of 2 quarters · filed 2018-05-01 | $386.40M derived: sum of 3 quarters · filed 2018-05-01 | $492.62M derived: sum of 4 quarters · filed 2018-05-01 |
| 2017-12-31 | $112.68M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $223.32M derived: sum of 2 quarters · filed 2018-02-27 | $329.54M derived: sum of 3 quarters · filed 2018-02-27 | $436.15M 10-K · filed 2018-02-27 |
| 2017-09-30 | $110.64M 10-Q · filed 2017-10-31 | $216.86M derived: sum of 2 quarters · filed 2017-10-31 | $323.47M 10-Q · filed 2017-10-31 | $431.71M derived: sum of 4 quarters · filed 2018-05-01 |
| 2017-06-30 | $106.22M 10-Q · filed 2017-08-01 | $212.83M 10-Q · filed 2017-08-01 | $321.07M derived: sum of 3 quarters · filed 2018-05-01 | $428.87M derived: sum of 4 quarters · filed 2018-05-01 |
| 2017-03-31 | $106.61M 10-Q · filed 2018-05-01 | $214.85M derived: sum of 2 quarters · filed 2018-05-01 | $322.65M derived: sum of 3 quarters · filed 2018-05-01 | $428.61M derived: sum of 4 quarters · filed 2018-05-01 |
| 2016-12-31 | $108.24M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $216.04M derived: sum of 2 quarters · filed 2018-02-27 | $322.00M derived: sum of 3 quarters · filed 2018-02-27 | $421.58M 10-K · filed 2018-02-27 |
| 2016-09-30 | $107.80M 10-Q · filed 2017-10-31 | $213.75M derived: sum of 2 quarters · filed 2017-10-31 | $313.34M 10-Q · filed 2017-10-31 | $409.38M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-06-30 | $105.95M 10-Q · filed 2017-08-01 | $205.54M 10-Q · filed 2017-08-01 | $301.58M derived: sum of 3 quarters · filed 2018-02-27 | $393.71M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-03-31 | $99.59M 10-Q · filed 2017-05-02 | $195.63M derived: sum of 2 quarters · filed 2018-02-27 | $287.76M derived: sum of 3 quarters · filed 2018-02-27 | |
| 2015-12-31 | $96.04M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $188.17M derived: sum of 2 quarters · filed 2018-02-27 | $359.06M 10-K · filed 2018-02-27 | |
| 2015-09-30 | $92.13M 10-Q · filed 2016-11-03 | $263.02M 10-Q · filed 2016-11-03 | ||
| 2014-12-31 | $248.50M 10-K · filed 2017-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |